Printer Friendly

Browse Hemophilia topic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
SHRED OF EVIDENCE; Fury at HIV blood scandal 'cover-up'. Alan Selby EXCLUSIVE Sep 27, 2020 633
Fury as HIV contaminated blood documents destroyed when scandal emerged; EXCLUSIVE: In a scandal which 'eclipses disasters like Hillsborough and Grenfell', campaigners say officials at the Department of Health shredded documents showing their failure as diseased blood products were given to Brits. By, Alan Selby Sep 26, 2020 804
Sundas Foundation president discusses thalassemia patients treatment with CM. Sep 13, 2020 223
President Sundas Foundation calls on Buzdar. Sep 13, 2020 216
General Knowledge Quiz. Sep 12, 2020 333
General Knowledge Quiz. Sep 11, 2020 333
Sanofi announces BIVV001 Phase 1/2a study results published in NEJM. Sep 10, 2020 154
General Knowledge Quiz. Sep 8, 2020 324
Sarepta added to Analyst Focus List, named a Top Idea at JPMorgan. Aug 25, 2020 167
BioMarin receives FDA CRL for BLA for valoctocogene roxaparvovec gene therapy. Aug 19, 2020 233
Haemophilia: A hidden condition. Aug 6, 2020 195
LOOKING AT LOGAN YOU WOULD NEVER KNOW THE FIGHT HE FACES EVERY DAY; Mum salutes son who lives with blood disorder... and the amazing party thrown by support group. CARLA TALBOT Aug 6, 2020 688
uniQure reports Q2 EPS (96c), consensus (67c). Financial report Jul 30, 2020 211
COVID-19: How the coronavirus affects people with bleeding disorders. Shyam A. Krishna, Senior Associate Editor Jul 28, 2020 1351
Ulema urge people for donating Hajj money to Sundas Foundation. Jul 20, 2020 156
Roche's Tecentriq Fails To Meet Ovarian Cancer Study Primary Endpoint. Jul 13, 2020 287
Roche's Spark Therapeutics Encouraged By SPK-8011 Results. Jul 13, 2020 206
Genentech says Phase IIIb STASEY study data reinforces Hemlibra safety profile. Jul 13, 2020 546
Catalyst Biosciences presents data at ISTH Virtual Congress. Jul 13, 2020 234
Genentech Says New Data from Phase IIIb Study Reinforces Safety Profile of Hemlibra in People with Hemophilia A. Jul 13, 2020 681
Takeda provides updates on Pharmacokinetic-guided Prophylaxis studies. Jul 12, 2020 541
Spark announces updated data on SPK-8011 from Phase 1/2 trial in Hemophilia A. Jul 12, 2020 457
Brave Zoe helping kids; charity worker struck down by a brain haemorrhage still helping ill youngsters. NICK LAVIGUEUR nick.lavigueur@reachplc.com @grecian9 Jul 10, 2020 368
uniQure, CSL Behring enter license agreement for hemophilia B gene therapy. Jun 24, 2020 462
Medexus fiscal 4Q revenue soars following IXINITY hemophilia drug acquisition. Jun 24, 2020 777
Sanofi And Regeneron's Dupixent Gets Green Light In China. Jun 22, 2020 225
Sanofi announces long-term efficacy, safety data for fitusiran. Jun 19, 2020 363
Catalyst Biosciences presents preclinical FIX gene therapy data. Jun 19, 2020 248
Pfizer, Sangamo announce updated follow-on data from Alta study. Jun 18, 2020 205
BioMarin provides updated data from Phase 1/2 study of hemophilia A candidate. Jun 17, 2020 279
Catalyst Biosciences presents final data from Phase 2b trial of DalcA. Jun 15, 2020 288
Takeda Pharmaceutical Reports Positive Hemophilia Studies Results. Jun 15, 2020 263
It is our responsibility to save lives of thalassemia patients: Ajab Gul. Jun 14, 2020 251
Catalyst Biosciences announces presentations at hemophilia virtual summit. Jun 8, 2020 175
Clinical Spectrum of Intracranial Bleeds in Patients with Bleeding Disorders- Experience from a Tertiary Center in Karnataka. Meera, V.; Smitha, R. Jun 8, 2020 2388
Regeneron, Intellia Therapeutics expand pact to develop CRISPR/Cas9 treatments. Jun 1, 2020 228
BioMarin provides update from Phase 1/2 study of Valoctocogene Roxaparvovec. May 31, 2020 489
AgeX Therapeutics announces collaboration with Sernova. May 29, 2020 292
US FDA grants Investigational New Drug Application approval to Expression Therapeutics' ET3. May 27, 2020 202
US FDA grants Investigational New Drug Application approval to Expression Therapeutics' ET3. May 27, 2020 198
Heydar Aliyev Foundation doing a remarkable works for treatment of patients suffering from thalassemia and hemophilia in Azerbaijan and abroad: Ali Alizada. May 14, 2020 615
uniQure presents preclinical data in SCA3, Fabry Disease, Hemophilia A. May 14, 2020 923
Another charitable initiative by Azercell [PHOTO]. May 13, 2020 500
Catalyst Biosciences receives EU patent for Factor IX portfolio. Apr 28, 2020 161
Catalyst Biosciences completes Phase 2b trial of SQ dalcinonacog alfa. Apr 21, 2020 198
Hamza Foundation holds awareness walk about Hemophilia diseases. Apr 18, 2020 253
Hamza Foundation holds awareness walk about Hemophilia diseases. Apr 18, 2020 253
Hamza Foundation holds awareness walk about Hemophilia diseases. Apr 18, 2020 221
Covid 19 and mental health. Danish Mali - Rawalpindi Apr 16, 2020 405
LFB Receives FDA Approval of Sevenfact, a New Recombinant Coagulation Factor VIIa, for the Treatment of Adults and Adolescents with Hemophilia A or B with Inhibitors. Apr 8, 2020 714
HEMA Biologics wins FDA approval of SEVENFACT for treating adult Hemophilia A and B patients with inhibitors. Apr 7, 2020 275
HEMA Biologics wins FDA approval of SEVENFACT for treating adult Hemophilia A and B patients with inhibitors. Apr 7, 2020 279
Thousands at risk due to blood shortage. Apr 4, 2020 158
SHC orders provision of PPE, testing kits to blood banks. Ishaq Tanoli Apr 4, 2020 823
US FDA approves Sevenfact for treatment of adults and adolescents with haemophilia A or B. Apr 2, 2020 264
US FDA approves Sevenfact for treatment of adults and adolescents with haemophilia A or B. Apr 2, 2020 268
Notices issued on plea against blood shortage due to lockdown. Apr 1, 2020 495
Doctor's Orders. Block, Daniel Apr 1, 2020 4998
Bleeding disorders community with C0VID-19 could face unique issues. Lesney, Mark S. Apr 1, 2020 717
Surgery in a Patient with Haemophilia A and Lymphoma. Cruz, M.S.; Santillan, J.; Lesser, J.; Ortiz, J.; Forzani, L.; Plaza, P. Mar 31, 2020 2290
The Liver That Cured Christmas: Case Report of Orthotopic Liver Transplant in a Patient with Hemophilia B. Harris, Jesse E.; Balk, Jonathan L.; Mobley, Constance M.; Heyne, Kirk Mar 31, 2020 2028
Aptevo Therapeutics looking to busy year ahead after transformative 2019 as it advances ADAPTIR pipeline. Mar 26, 2020 552
uniQure achieves target patient dosing in HOPE-B trial of AMT-061. Mar 26, 2020 260
Aptevo Therapeutics provides business update, FY20 cash burn rate of $28M-$30M. Mar 25, 2020 487
Novo Nordisk pauses trials of concizumab in haemophilia A and B patients. Mar 16, 2020 190
Analysis of Sasang Constitutional Medicine as an Optimal Preventive Care Strategy for Hemophilia Patients. Lee, Mi Kyung; Hwang, Minwoo; Oh, Hyunjoo; Kim, Kyoung Soo Mar 1, 2020 3630
Joint scores in hemophilic arthropathy in children: Developing country perspectives. Guha, Aritra; Rai, Akash; Nandy, Arnab; Mondal, Tanushree; Pandit, Narayan; Guha, Sumantra; Gupta, D Clinical report Mar 1, 2020 2907
HIV lie doc 'backed by top medic'. Jason Evans and Alan Selby EXCLUSIVE Feb 23, 2020 170
Anger at top doc's plea for medic jailed in HIV blood scandal; HAEMOPHILIA EXPERT SET TO FACE PROBE; Victims' families hit out. Jason Evans and Alan Selby Feb 23, 2020 491
Anger at top doc's plea for medic jailed in HIV blood scandal; HAEMOPHILIA EXPERT SET TO FACE PROBE Victims' families hit out. Jason Evans and Alan Selby Feb 23, 2020 491
Outrage as leading medic supports HIV doctor after infecting 1,000 people; EXCLUSIVE: Dr Christopher Ludlam said Dr Jean-Pierre Allain should keep his job -despite 1,243 people being infected with HIV through his Factor VIII blood product in the 1980s. By, Jason Evans & Alan Selby Feb 22, 2020 186
BioMarin Pharmaceutical files BLA with US FDA for valoctocogene roxaparvovec for treating adults with haemophilia A. Feb 21, 2020 267
BioMarin Pharmaceutical files BLA with US FDA for valoctocogene roxaparvovec for treating adults with haemophilia A. Feb 21, 2020 271
Family 'petrified' because baby son has 'all the coronavirus symptoms'; The baby boy and his mum are in quarantine at their Worthing, East Sussex, home after coming into contact with an infected GP, with the eight-month-old already suffering with haemophilia and a lung condition. By, Ryan Merrifield Feb 13, 2020 1073
Epirium Bio Appoints Former BioMarin Program Lead Ransi Somaratne as Chief Medical Officer. Feb 10, 2020 346
Bone and Joint Center specilaised clinic helps improve haemophilic patients' care. Jan 19, 2020 675
HMC Center provides streamlined orthopaedic care for haemophilia patients. Jan 18, 2020 515
ASC Therapeutics partners with Vigene for gene therapy development and manufacturing. Jan 15, 2020 214
ASC Therapeutics partners with Vigene for gene therapy development and manufacturing. Jan 15, 2020 210
Clinico-Haematological Profile of Haemophilia in Patients Attending Gandhi Medical College and Associated Hamidia Hospital, Bhopal. Nigam, Rajendra Kumar; Sharma, Praveen; Choudhary, Rajni; Malik, Reeni Jan 6, 2020 2830
Gene Therapy May Be Long-Term Cure for Type of Hemophilia. Dennis Thompson, HealthDay Reporter Jan 2, 2020 649
Vascularized Free Tissue Transfer in a Patient with Hemophilia B: Case Report and Literature Review. Qaisi, Mohammed; Kierce, Justin; Murphy, James Jan 1, 2020 4178
New injection 'will change Joshua's life'. JAMIE HALL Dec 27, 2019 410
Sangamo reports transfer of SB-525 Hemophilia A Gene Therapy IND. Dec 24, 2019 191
Sangamo reports transfer of SB-525 Hemophilia A Gene Therapy IND. Dec 24, 2019 187
Sangamo Completes Early Transfer to Pfizer of SB-525 Hemophilia A Gene Therapy IND and an Earned USD 25m Milestone Payment. Dec 24, 2019 268
Therapeutic Proteins Market Increasing Demand, Latest Trends & Huge Business Prospects In Healthcare Industry By 2020 / Radiant Insights, Inc. Dec 23, 2019 891
Syncona Commits USD80 Million Investment Into Freeline Therapeutics. Dec 19, 2019 202
Iranian Patients Breathe Hard due to US Sanctions on Medical Imports. Dec 17, 2019 1179
Regulators Give Roche Green Light For $4.3B Spark Therapeutics Acquisition. Tanzeel Akhtar Dec 17, 2019 302
Roche's Spark Therapeutics Deal Gets Approval From UK Regulator. Dec 16, 2019 267
Bleeding Disorders Treatment Market Growth Insights, Sales Projection, Leading Companies, Future Trends and Application By 2023. Dec 12, 2019 1011
Global Therapeutic Proteins Market Report 2020: Market was Valued at $93.14 Billion in 2018 and is Expected to Grow to $172.87 Billion through 2022. Report Dec 10, 2019 653
Takeda and Virgin Pulse Support Patients with Bleeding Disorders to Adopt Healthier Lifestyles. Dec 6, 2019 999
Global Hemophilia Treatment Drugs Market Drivers, Restraints & Opportunities During the Forecast Period, 2018-2026. Dec 5, 2019 820
Ascension Healthcare plc Announces Distribution Agreement with Apex - Press Release issued by Ascension Healthcare plc. Dec 3, 2019 817
Hemophilia Treatment Market Analysis 2019: Global Size, Recent Trends, Opportunity Assessment, Future Scope and Potential of Industry Growth By Top Leaders. Dec 3, 2019 865
Plasma Fractionation Market 2019 Global Industry Size, Share, Key Players Analysis, Emerging Trends, Global Opportunities, Competitive Landscape and Regional Forecast 2023. Nov 26, 2019 1194
Global Recombinant Plasma Protein Therapeutics Market - Industry Analysis, Size, Share, Growth, Trends & Forecast 2018-2026. Nov 25, 2019 1194
Option Care Health Selected by Highmark as Preferred Provider of Hemophilia Treatment. Nov 19, 2019 923
Joshua films inspiring message for other kids. DALE HASLAM Nov 18, 2019 506
Hemophilia Treatment Market Dynamics, Pin-Point Analysis, Comprehensive Landscape, Demand Key Factors, Market Segments Regions, Therapy For Hemophilia (A, B, C) and Industry Forecast To 2023. Industry overview Nov 18, 2019 891
Calliditas Therapeutics appoints new CMO. Nov 15, 2019 211
Calliditas Therapeutics appoints new CMO. Nov 15, 2019 207
Bleeding Disorders Treatment Market Share Analysis, Future Growth Insights, Share Value, Leading Players and Global Industry Trends By 2023. Nov 15, 2019 1152
Every effort will be made to uplift the health sector: CM Kamal. Nov 6, 2019 226
Fatimid Foundation chairman calls on Balochistan CM. Nov 6, 2019 227
Every effort will be made to uplift the health sector: CM Kamal. Nov 6, 2019 222
Steps afoot to provide healthcare facilities to masses in public hospitals: CM. Nov 6, 2019 322
Intron 22 inversion real-time polymerase chain reaction detection in haemophilia A families from central South Africa. Kloppers, J.F.; Marx, G.M.; van Rensburg, W.J. Janse Nov 1, 2019 3024
Advanced Textbook on Gene Transfer, Gene Therapy and Genetic Pharmacology: Principles, Delivery and Pharmacological and Biomedical Applications of Nucleotide-Based Therapies, 2nd Edition. Brief article Nov 1, 2019 143
VC Islamia University visits blood transfusion center. Oct 31, 2019 163
Hemophilia A and B: Global Drug Forecast & Market Analysis, 2019-2028. Oct 31, 2019 1286
uniQure announces publication of interim data from Phase IIb clinical trial. Oct 31, 2019 217
Leptin and Adiponectin Signaling Pathways Are Involved in the Antiobesity Effects of Peanut Skin Extract. Xiang, Lan; Wu, Qiaobei; Cheng, Lihong; Sun, Kaiyue; Li, Jing; Yoshida, Minoru; Qi, Jianhua Oct 31, 2019 7623
uniQure reports Q3 EPS (58c), consensus (81c). Financial report Oct 28, 2019 122
uniQure exprects top-line data for HOPE-B pivotal study before end of 2020. Oct 28, 2019 116
uniQure expects to initiate IND-enabling studies for AMT-150 in 1H20. Oct 28, 2019 197
BioMarin reports Q3 EPS 30c, consensus 6c. Financial report Oct 23, 2019 242
Creative Biolabs Makes Efforts to Improve the Stem Cell Therapy Development. Oct 22, 2019 532
Chugai Pharmaceutical Co., Ltd. - Data on the use of Chugai's Hemlibra in Hemophilia A Children with or without Inhibitors were Published in Journals -- 18/10/2019. Oct 22, 2019 504
bluebird bio partners with Novo Nordisk to develop in vivo genome editing candidates for haemophilia. Oct 10, 2019 262
bluebird bio partners with Novo Nordisk to develop in vivo genome editing candidates for haemophilia. Oct 10, 2019 263
bluebird bio partners with Novo Nordisk to develop in vivo genome editing candidates for haemophilia. Oct 10, 2019 258
Blood Coagulants Market Growth By Top Leading Players, Size, Share, Trends, Demand, Global Industry Overview By Type, Indication, End-User and Forecast to 2023. Industry overview Oct 9, 2019 897
bluebird bio and Novo Nordisk enter into research agreement to develop in vivo genome editing candidates for haemophilia and other severe genetic diseases. Oct 9, 2019 1226
Bluebird Bio, Novo Nordisk enter genome editing research collaboration. Oct 9, 2019 119
Thalassemia and Hemophilia Seminar. Oct 7, 2019 133
Rare Hemophilia Factors Market To Witness Huge Growth Potential From 2014 To 2025 - In-Depth Industry Research Report By Million Insights. Report Oct 3, 2019 802
Catalyst says two subjects exceed efficacy endpoint in DalcA Phase 2b study. Oct 3, 2019 220
Acquired Hemophilia A (FVIII Deficiency) Associated with Papillary Thyroid Cancer: Treatment with Recombinant Porcine FVIII. Nguyen, S.; Teh, P.; Zhou, J.; Chang, E.Y.; von Drygalski, A. Sep 30, 2019 2692
General Knowledge Quiz. Sep 20, 2019 319
Hematology Market 2019: Global Key Players, Trends, Share, Industry Size, Segmentation, Opportunities, Forecast To 2025. Sep 19, 2019 650
Nucleic Acid-Based Therapeutics Market - Trends, Size, Technology Growth, Key Players, Future Scope, Global Opportunity and Regional Industry Share Analysis 2019 - 2022. Sep 19, 2019 885
Corporate Reputation of Pharma in 2018 from Bleeding Disorders Patients: The Views of 27 Patient Groups of Bayer, CSL Behring, Grifols, Novo Nordisk, Octapharma, Pfizer, Roche, Takeda/Shire. Sep 19, 2019 651
General Knowledge Quiz. Sep 18, 2019 313
Awareness is in the jeans. Sep 18, 2019 165
Weekly Puzzles; General Knowledge Quiz. Sep 16, 2019 321
Von Willebrand Disease Treatment Market Forecast Covering Revenue & Growth Inclinations & Developmen. Sep 16, 2019 991
1,125,000 Men/Boys Expected to Have Hemophilia Worldwide; Prevalence of all severities of hemophilia A and hemophilia B estimated at 17.1 and 3.8 cases per 100,000. Sep 10, 2019 278
Rs2.5b thalassemia hospital to be constructed in Peshawar: Haleem. Sep 6, 2019 207
uniQure achieves planned enrollment in HOPE-B trial of AMT-061. Sep 3, 2019 232
uniQure has significant first mover advantage in Hem B, says H.C. Wainwright. Sep 3, 2019 121
Home therapy for inherited bleeding disorders in South Africa: Results of a modified Delphi consensus process. Mahlangu, J.N.; Naidoo, Y.; Goga, Y.; Vaithlingum, M.; Joubert, J.; Sutton, C.; Potgieter, J.; Cruic Sep 1, 2019 5084
New HA and HB therapies offer innovation for patients and expanded testing opportunities for laboratories. Riley, Paul Sep 1, 2019 1655
Von Willebrand Disease Treatment Market 2018-2028 Shares, Trend and Growth Report. Aug 24, 2019 1229
Hemophilia Gene Therapy Market, 2018-2028 by Segmentation: Based on Product, Application and Region. Aug 20, 2019 1037
Haemophilia: Keep Away From Ginger, Dietician Advises. Aug 17, 2019 578
Recombinant Plasma Protein Therapeutics Market Size, Share, Trends and Future Growth Predictions and. Aug 14, 2019 1072
Recombinant Plasma Protein Therapeutics Market Size, Share, Trends and Future Growth Predictions and. Aug 13, 2019 1085
Sangamo reports Q2 EPS (26c), consensus (36c). Financial report Aug 7, 2019 279
'I do worry about what the future might hold for Joshua'. Aug 3, 2019 732
Justice for Anthony, justice for all. Aug 3, 2019 914
Global Hemophilia Market Analysis by Type, Treatment, Therapy, and Region - Forecast to 2024. Aug 1, 2019 769
Recombinant Protein Market: Biopharmaceutical Companies will Continue to be the Fastest Expanding En. Jul 31, 2019 888
Recombinant Protein Market: Biopharmaceutical Companies will Continue to be the Fastest Expanding En. Jul 30, 2019 902
uniQure says advancing 'robust pipeline of novel gene therapy research programs'. Jul 29, 2019 364
World Hepatitis Day observed in Peshawar. Jul 29, 2019 217
'HIV dad told to drop assault complaint or his attackers could sue him'. Jul 27, 2019 715
General Knowledge Quiz. Jul 27, 2019 343
'HIV dad told to drop assault complaint or his attackers could sue him'. Jul 27, 2019 706
Father had HIV diagnosis withheld from him, inquiry told. Jul 26, 2019 597
Excessive Bleeding: Haematologist Advocates Govt Support For Haemophilia Patients. Jul 22, 2019 394
Chugai Pharmaceutical Co., Ltd. - Further Clinical Data including Long-Term Follow-up for Chugai's Hemlibra Presented at ISTH -- 9/7/2019. Jul 16, 2019 1007
BRAIN TEST HORROR; Blood inquiry told of invasive surgery after boy dies. Jul 12, 2019 243
Genentech Presents a Broad Range of Data for Hemlibra Demonstrating Continued Benefits for People with Hemophilia A at the ISTH 2019 Congress. Jul 12, 2019 1376
Sigilon Therapeutics Presents Data Demonstrating Feasibility of Shielded Living Therapeutics Platform for Hemophilia A at ISTH 2019 Congress. Jul 12, 2019 341
Logan and Lisa give charity a PS1.2k thank you. Jul 11, 2019 505
Lives 'devastated' by tainted transfusions; Inquiry: Wife of haemophiliac shares hour-long testimony. Jul 10, 2019 650
BioMarin weakness 'a buying opportunity' ahead of Q4 catalysts, says Wedbush. Jul 10, 2019 134
Recombinant Plasma Protein Therapeutics Market Analyzed for the Projected Period of 2018 -- 2026. Jul 10, 2019 1084
Recombinant Plasma Protein Therapeutics Market Analyzed for the Projected Period of 2018 -- 2026. Jul 10, 2019 1071
Pfizer and Sangamo reveal details of phase 1/2 Alta study of SB-525 haemophilia A gene therapy. Jul 9, 2019 203
Pfizer and Sangamo reveal details of phase 1/2 Alta study of SB-525 haemophilia A gene therapy. Jul 9, 2019 199
Takeda Release New Data from the PROPEL Study at ISTH 2019, Reinforcing the Potential Benefit for Personalised Prophylaxis with Adynovate in Severe Hemophilia A. Clinical report Jul 9, 2019 394
Octapharma Present New Data on the Benefits of Nuwiq In Patients with Haemophilia A. Jul 9, 2019 659
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) - BioMarin Plans Regulatory Submissions for Marketing Authorization of Valoctocogene Roxaparvovec to Treat Severe Hemophilia A in 4Q 2019 in both U.S. and Europe -- 8/7/2019. Jul 9, 2019 1181
Swedish Orphan Biovitrum AB announces interim results from verITI-8 study of Elocta for Immune Tolerance Induction for severe haemophilia A with inhibitors. Clinical report Jul 8, 2019 367
Swedish Orphan Biovitrum AB updates results of MIND study in people with haemophilia. Jul 8, 2019 347
Swedish Orphan Biovitrum AB announces interim results from verITI-8 study of Elocta for Immune Tolerance Induction for severe haemophilia A with inhibitors. Clinical report Jul 8, 2019 363
Swedish Orphan Biovitrum AB updates results of MIND study in people with haemophilia. Jul 8, 2019 343
ISTH reports first of its kind global education in haemophilia. Jul 8, 2019 289
The International Society on Thrombosis and Haemostasis launches Gene Therapy in Hemophilia. Jul 8, 2019 168
ISTH reports first of its kind global education in haemophilia. Jul 8, 2019 285
The International Society on Thrombosis and Haemostasis launches Gene Therapy in Hemophilia. Jul 8, 2019 164
Catalyst Biosciences Phase 2 trial of MarzAA met primary endpoint. Jul 8, 2019 126
Novo Nordisk says concizumab showed favorable safety profile in Phase 2 studies. Jul 8, 2019 141
BioMarin plans to submit marketing applications for valoctocogene roxaparvovec. Jul 8, 2019 106
Fly Intel: Pre-market Movers. Jul 8, 2019 294
Coagulation Factor IX Market Perceptions Targeting Industrial Expansion Studied during the Forecast. Jul 8, 2019 819
Sangamo, Pfizer announce updated Phase 1/2 Alta study results for SB-525. Jul 7, 2019 304
uniQure announces follow-up data from Phase IIb study of AMT-061, AMT-060. Jul 7, 2019 589
Man kept in the dark over blood infection. Jul 5, 2019 419
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) - BioMarin Announces Acceptance of Late Breaking Abstract at the International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress in Melbourne, Australia from July 6-10, 2019 -- 26/6/2019. Jul 4, 2019 312
Blood scandal records 'missing'. Jul 4, 2019 228
Tearful dad tells how son died of Aids; Blood scandal: Records 'destroyed'. Jul 4, 2019 350
Hemophilia Gene Therapy Market Scenario Focusing on Improvements Shaping Industry Growth. Jul 4, 2019 882
Hemophilia Gene Therapy Market Investigation & Industry Evolution till 2028. Jul 4, 2019 867
Mum accuses docs in blood scandal probe. Jul 3, 2019 221
'My brother's grave was defaced... we were branded the AIDS family'. Jul 3, 2019 347
Novo Nordisk receives EU marketing authorisation for Esperoct. Jun 21, 2019 198
Novo Nordisk receives EU marketing authorisation for Esperoct. Jun 21, 2019 199
Novo Nordisk receives EU marketing authorisation for Esperoct. Jun 21, 2019 194
Transfusion victim's '36-year nightmare' LIFE BLIGHTED BY HEPATITIS. Jun 21, 2019 1075
Inquiry told of man's hepatitis C bombshell. Jun 14, 2019 273
Man lost four of his brothers in NHS infected blood scandal. Jun 13, 2019 589
Coagulation Factor IX Market Investigation and Growth Forecasted Until the End of 2026. Jun 12, 2019 819
Inquiry told 'stigmatising' medical bags left outside widow's home. Jun 12, 2019 1495
Vandals defaced my brother's grave and threw stones at it... MAN TELLS INFECTED BLOOD INQUIRY OF FAMILY'S HELL. Jun 12, 2019 579
BioMarin hemophilia A potential larger than anticipated, says Cantor Fitzgerald. Jun 10, 2019 102
Evaluation of Unfavorable Cardiovascular and Metabolic Risk Factors in Children and Young Adults with Haemophilia. Yildiz, Melek; Ozdemir, Nihal; Onal, Hasan; Koc, Basak; Tipici, Beyza Eliuz; Zulfikar, Bulent Jun 1, 2019 5292
Roche. Jun 1, 2019 139
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) - BioMarin Announces that Phase 3 Cohort of Valoctocogene Roxaparvovec, Gene Therapy Study in Severe Hemophilia A Met Pre-Specified Criteria for Regulatory Submissions in the U.S. and Europe -- 28/5/2019. May 29, 2019 617
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) - BioMarin Provides 3 Years of Clinical Data from Ongoing Phase 1/2 Study of Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A -- 28/5/2019. May 29, 2019 1541
BioMarin: valoctocogene roxaparvovec met pre-specified criteria for review. May 28, 2019 561
BioMarin: valoctocogene roxaparvovec met pre-specified criteria for review. May 28, 2019 561
BioMarin says valoctocogene roxaparvovec bleed control maintained for third year. May 28, 2019 265
Chief Secretary lauds services of Hamza Foundation Hospital. May 27, 2019 259
CS applauds HFWH for serving blood genetic disorder patients. May 27, 2019 252
Infected blood victim asked wife to kill him; Widow tells inquiry of 'gentle giant's' torment; Respected teacher's hellish final days revealed. May 25, 2019 637
LIVES ARE STILL BEING LOST TO INFECTED BLOOD; Sufferer tells probe of pain. May 22, 2019 391
uniQure's AMT-061 looking 'clearly superior' to competition, says Piper Jaffray. May 12, 2019 134
PM criticised for scandal response; UK & WORLD. May 11, 2019 174
PM criticised for scandal response; UK & WORLD. May 11, 2019 174
uniQure presents updated Phase 2b AMT-061 data at HTRS. May 10, 2019 357
Coagulation Factor IX Market to Deliver Prominent Growth & Striking Opportunities during 2018-2026. May 9, 2019 777
Coagulation Factor IX Market to Deliver Prominent Growth & Striking Opportunities during 2018-2026. May 9, 2019 819
Health Ministry sends 15 truckloads of medical supplies to Gaza. May 8, 2019 131
Give us justice, says father in blood scandal. May 4, 2019 321
Give us justice, says father in blood scandal. May 4, 2019 321
'Haemophilia injections'. May 2, 2019 266
Valrox could become BioMarin's largest product, says Jefferies. May 2, 2019 149
Infected blood victim 'arranged funeral in hospital'. May 1, 2019 157
Infected blood victim 'arranged funeral in hospital'. May 1, 2019 158
Adaptive Biotechnologies Names Baldo as Chief Medical Officer. Apr 30, 2019 317
Novo Nordisk announces receipt of positive opinion from CMPH for Esperoct for the treatment of haemophilia A in Europe. Apr 29, 2019 220
Novo Nordisk announces receipt of positive opinion from CMPH for Esperoct for the treatment of haemophilia A in Europe. Apr 29, 2019 216
Coagulation Factor IX Market Projects Greater Demand Owing to Higher Contribution by Leading Players. Apr 29, 2019 781
Cantor continues to see 'highly favorable' risk/reward on BioMarin shares. Apr 26, 2019 108
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN). Apr 25, 2019 2243
'Voluntary blood donation can help haemophilia patients'. Apr 19, 2019 464
Medical expert calls for 'public awareness' on World Hemophilia Day. Apr 18, 2019 451
HWSK marks 'World Haemophilia Day'. Apr 18, 2019 485
New multidisciplinary clinic improving care for patients with haemophilia. Apr 17, 2019 857
Recombinant Protein Therapy Market: Toxicity Screening, and Drug Discovery Will Witness the Fastest. Apr 15, 2019 768
uniQure says six data presentations to be delivered at ASGCT. Apr 15, 2019 111
Logan faces a lifetime of injections ... but brave tot takes it in his stride; Youngster diagnosed with haemophilia at six months. Apr 13, 2019 547
Capital police to arrange blood for thalassaemia centre. Apr 13, 2019 374
Thalassemia test at district's hospitals being considered: DC. Apr 11, 2019 182
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN). Apr 11, 2019 2243
Inspirational mum helps son to shine. Apr 10, 2019 245
Hemophilia awareness seminar on April 17. Apr 10, 2019 162
Hemophilia awareness seminar on April 17. Apr 10, 2019 136
Sangamo Therapeutics and Pfizer reveal interim data from haemophilia Phase 1/2 Alta study. Apr 4, 2019 283
Sangamo Therapeutics and Pfizer reveal interim data from haemophilia Phase 1/2 Alta study. Apr 4, 2019 279
Seminar on Hemophilia on April 17. Apr 4, 2019 115
Sangamo, Pfizer Release Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy. Apr 3, 2019 702
Sangamo, Pfizer announce Phase 1/2 interim data for SB-525 gene therapy. Apr 2, 2019 392
Fly Intel: Pre-market Movers. Apr 2, 2019 226
Sangamo price target raised to $34 from $24 at Wells Fargo. Apr 2, 2019 135
Catalyst Biosciences receives orphan drug desgination for MarzAA in EU. Apr 1, 2019 202
A Case of Acquired Haemophilia A in a Patient with Chronic Myelomonocytic Leukaemia. Araki, Takeshi; Ohata, Shinya; Okamoto, Kohei; Morimoto, Kazuhide; Hiraishi, Mana; Yamada, Shinichir Mar 31, 2019 3952
Understanding Hemophilia for All Ages. Mar 28, 2019 606
Hemophilia Gene Therapy Market to Record an Exponential CAGR by 2028. Mar 21, 2019 1017
Coagulation Factor IX Market Expansion Projected to Gain an Uptick During 2018 to 2026. Mar 21, 2019 1157
The European Commission approves Roche's haemophilia drug Hemlibra. Mar 15, 2019 162
The European Commission approves Roche's haemophilia drug Hemlibra. Mar 15, 2019 158
Roche announces EC approval of Hemlibra. Mar 14, 2019 145
Sangamo announces publication of ZFN data in Nature Communications. Mar 8, 2019 151
UoS blood camp for thalassemia patients. Mar 7, 2019 264
GLASGOW IS STANDOUT PERFORMER IN EVENTS BOOM. Mar 5, 2019 2136
Blood diseases treatment centers may rise: official. Mar 3, 2019 226
BM Group supports World Hemophilia Day 2019. Feb 28, 2019 311
Coagulation Factor IX Market Dynamics, Forecast, Analysis and Supply Demand 2018-2026. Feb 26, 2019 843
Cantor sees uniQure as next gene therapy buyout, ups price target to $81. Feb 25, 2019 103
Roche may spark another bull run for gene therapy names, says Credit Suisse. Feb 25, 2019 132
Hemophilia: Raising children with the bleeding disorder. Feb 25, 2019 1314
CHOOSING SMART EMBRYOS ISN'T IMMORAL. Bailey, Ronald Feb 21, 2019 675
Novo Nordisk announces approval of Biologics License Application for ESPEROCT by US FDA. Feb 20, 2019 308
Novo Nordisk announces approval of Biologics License Application for ESPEROCT by US FDA. Feb 20, 2019 304
uniQure announces updated data on Phase 2b AMT-061 trial. Feb 8, 2019 370
Catalyst Biosciences presents interim FVIIa data at EAHAD. Feb 8, 2019 300
Takeda Show Results from First-of-Its-Kind Phase IIIb/IV Trial PROPEL a Randomized PK-Guided Prophylaxis Study Evaluating Higher Factor VIII Levels in Hemophilia Aat EAHAD 2019. Clinical report Feb 7, 2019 335
Catalyst study results show four-fold reduction in bleeding time for CB 2679d-GT. Feb 6, 2019 192
Report: Jury orders Takeda to pay Bayer $155M over hemophilia drug. Perry, Jessica Brief article Feb 6, 2019 241
uniQure announces first patient treated in HOPE-B trial of AMT-061. Feb 4, 2019 178
Chugai's Hemlibra Gains Positive CHMP Opinion in Severe Hemophilia a Without Inhibitors. Feb 4, 2019 296
Roche says CHMP recommends EU approval of Hemlibra. Feb 1, 2019 183
Advances in the Treatment of Hemophilia: Implications for Laboratory Testing. Tripodi, Armando; Chantarangkul, Veena; Novembrino, Cristina; Peyvandi, Flora Clinical report Feb 1, 2019 6116
Helping poorly children feel better with MOMENTS OF MAGIC; hospital launches PS75,000 christmas campaign. Dec 7, 2018 815
At ASH, Extended Half-Life Therapies Eloctate and Alprolix Demonstrate Proven Efficacy and Well-Characterised Safety over Four Years. Dec 4, 2018 569
uniQure announces updated AMT-060 results, AMT-061 update at ASH. Financial report Dec 3, 2018 248
Genentech's Hemlibra provided sustained bleed control in pivotal study. Dec 3, 2018 258
Catalyst announces positive data from Phase 2/3 study of Marzeptacog Alfa. Dec 2, 2018 302
Global Cryoprecipitated Antihemophilic Factor Market Expected to Secure Notable Revenue Share during. Nov 19, 2018 333
Spark Therapeutics upgraded to Neutral from Underperform at Credit Suisse. Nov 16, 2018 162
On The Fly: Top five analyst upgrades. Nov 16, 2018 230
uniQure announces data from dose-confirmation study of AMT-061. Nov 15, 2018 417
JPMorgan downgrades Sangamo to Neutral on 'growing skepticism'. Nov 14, 2018 105
Single father of 5 kids suffering from rare blood disorder. Nov 12, 2018 242

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters